Martin Bentz

Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

Hartmut Döhner, Stephan Stilgenbauer, Axel Benner et al. · New England Journal of Medicine · 2000 · 3.3K citations

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

H. Döhner, Konstanze Fischer, Martin Bentz et al. · Blood · 1995 · 732 citations · Full text

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

Andreas Engert, Volker Diehl, Jeremy Franklin et al. · Journal of Clinical Oncology · 2009 · 494 citations · Full text

11q Deletions Identify a New Subset of B-Cell Chronic Lymphocytic Leukemia Characterized by Extensive Nodal Involvement and Inferior Prognosis

Hartmut Döhner, Stephan Stilgenbauer, Michael R. James et al. · Blood · 1997 · 437 citations · Full text

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe et al. · The Lancet · 2017 · 372 citations

Positron Emission Tomography, Advanced-stage Hodgkin, Lymphoid Neoplasia +9